絞り込み

18371

広告

1418件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Expression Patterns of CD44 and AREG Under Treatment With Selective Tyrosine Kinase Inhibitors in HPV and HPV Squamous Cell Carcinoma.

Sequential afatinib and osimertinib in patients with mutation-positive non-small-cell lung cancer: final analysis of the GioTag study.

Therapeutic Potential of Afatinib in NRG1 Fusion-Driven Solid Tumors: A Case Series.

The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation.

TNF Inhibitor Pomalidomide Sensitizes Glioblastoma Cells to EGFR Inhibition.

Correction to: Afatinib is active in osteosarcoma cell lines.

Survival analysis of afatinib versus erlotinib for individuals with advanced del19 lung adenocarcinoma with asymptomatic brain metastasis after pemetrexed-cisplatin chemotherapy: a retrospective study.

Quantification of [F]afatinib using PET/CT in NSCLC patients: a feasibility study.

Multiomics profiling of paired primary and recurrent glioblastoma patient tissues.

Implications of lipid droplets in lung cancer: Associations with drug resistance.

Photo-induced specific intracellular release EGFR inhibitor from enzyme/ROS-dual sensitive nano-platforms for molecular targeted-photodynamic combinational therapy of non-small cell lung cancer.

Response to tyrosine kinase inhibitors in lung adenocarcinoma with the rare epidermal growth factor receptor mutation S768I and G724S: A case report and literature review.

Zebrafish xenograft model of human lung cancer for studying the function of LINC00152 in cell proliferation and invasion.

Making the case for EGFR TKI sequencing in mutation-positive NSCLC: a GioTag study US patient analysis.

Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma.

Role of YES1 amplification in EGFR mutation-positive non-small cell lung cancer: Primary resistance to afatinib in a patient.

Afatinib in patients with advanced non-small cell lung cancer harboring HER2 mutations, previously treated with chemotherapy: A phase II trial.

Synergistic drug combinations and machine learning for drug repurposing in chordoma.

Retroperitoneal Metastasis, With Marked Fibrosis, of Lung Adenocarcinoma after Afatinib Treatment: An Autopsy Case Report.

Leptomeningeal Metastases in Non-small Cell Lung Cancer: Optimal Systemic Management in NSCLC With and Without Driver Mutations.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります